Adapting to Evolving Technologies and Treatment Guidelines in a Procedural Trial: A Qualitative Review of the CREST-2 Experience
- PMID: 36746636
- PMCID: PMC10259285
- DOI: 10.1212/WNL.0000000000207075
Adapting to Evolving Technologies and Treatment Guidelines in a Procedural Trial: A Qualitative Review of the CREST-2 Experience
Abstract
Multiple challenges confront procedural trials, including slow enrollment, lack of equipoise among patients and physicians, and failure to achieve adequate masking. Nonetheless, randomized clinical trials provide the best evidence of efficacy. The evolution of technology, techniques, and standards of care during the conduct of procedural trials challenges external validity. In this study, we review how a multicenter trial of revascularization of asymptomatic carotid arteries for stroke prevention has managed changes in treating carotid stenosis and medical management of atherothrombotic disease. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov number: NCT02089217.
Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
Conflict of interest statement
J.F. Meschia receives National Institute for Neurological Disorders and Stroke (NINDS) grant support for efforts on the CREST-2 trial. B.K. Lal receives NINDS grant support for efforts on the CREST-2 trial. G.S. Roubin receives NINDS grant support for efforts on the CREST-2 trial. In addition, he has equity holdings in Contego Medical Inc., Inspire MD Inc., Excision Medical Inc., and CardioMech Inc. T.N. Turan receives NINDS grant support for efforts on the CREST-2 trial. V.J. Howard receives NINDS grant support for efforts on the CREST-2 trial. R.T. Benson reports no disclosures relevant to the manuscript. K. Carman receives NINDS grant support for efforts on the CREST-2 trial. G. Howard receives NINDS grant support for efforts on the CREST-2 trial. T.G. Brott receives NINDS grant support for efforts on the CREST-2 trial. Go to
Figures
References
-
- Eckstein HH, Reiff T, Ringleb P, Jansen O, Mansmann U, Hacke W. SPACE-2: a missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg. 2016;51(6):761-765. doi:10.1016/j.ejvs.2016.02.005. - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical